(Q41927429)

14 October 2017

Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1. (English)

1 reference

14 October 2017

1 reference

1 reference

Sperber K

1

1 reference

14 October 2017

Chiang G

2

1 reference

14 October 2017

Chen H

3

1 reference

14 October 2017

Ross W

4

1 reference

14 October 2017

Chusid E

5

1 reference

14 October 2017

Gonchar M

6

1 reference

14 October 2017

Chow R

7

1 reference

14 October 2017

Liriano O

8

1 reference

14 October 2017

1 September 1997

1 reference

14 October 2017

Clinical Therapeutics

1 reference

14 October 2017

19

1 reference

14 October 2017

5

1 reference

14 October 2017

913-923

1 reference

Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes

14 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Antimalarials in the management of discoid and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Ophthalmologic safety of long-term hydroxychloroquine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Production of hybridoma growth factor by human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Therapy for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Distribution of the enantiomers of hydroxychloroquine and its metabolites in ocular tissues of the rabbit after oral administration of racemic-hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

AIDS--the second decade: a global perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980045-8

7 January 2021

10.1016/S0149-2918(97)80045-8

Identifiers

DOI

1 reference

14 October 2017

1 reference